ARNA NASDAQ
Arena Pharmaceuticals, Inc.
1W: +6.3%
1M: +8.0%
3M: +82.8%
1Y: +32.2%
3Y: +118.6%
5Y: +594.4%
$99.99
Last traded 2022-03-10 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-83.1% YoY
$-617M
Net Income
-52.6% YoY
$-523M
Free Cash Flow
-47.8% YoY
100.0%
Gross Margin
-286305.6%
Op. Margin
-290025.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-70.4%
ROA-62.5%
ROIC-301.3%
Valuation
P/E-8.8
P/B8.1
EV/EBITDA-8.5
Leverage
Debt/Equity0.06
Current Ratio8.59
Interest Cov.-160.4x
Quality Scores
Piotroski F1/9
Altman Z25.60
Beneish M0.53